Compare $DRMA vs $GRI | Chartloom

Compare

$DRMA vs $GRI

Dermata Therapeutics Inc · GRI Bio Inc

DRMA

Dermata Therapeutics Inc

GRI

GRI Bio Inc

Compare $DRMA vs $GRI

Comparing Dermata Therapeutics Inc and GRI Bio Inc

DRMADermata Therapeutics Inc

GRIGRI Bio Inc

DRMADermata Therapeutics Inc

Market cap

$4M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

11.49x

Rev growth (TTM)

—

YTD performance

-53.2%

52W performance

-78.7%

FCF yield

-198.6%

GRIGRI Bio Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-77.8%

52W performance

-96.7%

FCF yield

-338.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DRMA

GRI

Detailed metrics comparison

DRMA

Dermata Therapeutics Inc

GRI

GRI Bio Inc

Market Cap

DRMA$4M

GRI$3M

Enterprise Value

DRMA$-312K

GRI$-8M

Price

DRMA$1.02

GRI$1.74

P/E Ratio

DRMAN/A

GRIN/A

P/S Ratio

DRMA0.00x

GRI0.00x

EV/Sales

DRMA0.00x

GRI0.00x

EV/EBITDA

DRMA0.00x

GRI0.00x

P/B Ratio

DRMA1.27x

GRI0.42x

P/FCF Ratio

DRMAN/A

GRIN/A

EV/FCF

DRMA0.04x

GRI0.76x

PEG Ratio

DRMAN/A

GRIN/A

Forward P/E (NTM)

DRMAN/A

GRIN/A

Forward P/S (NTM)

DRMA11.49x

GRIN/A

Revenue (TTM)

DRMA$0

GRI$0

Revenue Growth (YoY)

DRMAN/A

GRIN/A

Forward Rev Growth

DRMA650.0%

GRI0.0%

Gross Margin (TTM)

DRMA0.0%

GRI0.0%

Operating Margin (TTM)

DRMA0.0%

GRI0.0%

EBITDA Margin (TTM)

DRMA0.0%

GRI0.0%

Net Margin (TTM)

DRMA0.0%

GRI0.0%

FCF Margin (TTM)

DRMAN/A

GRIN/A

Net Income (TTM)

DRMA$-8M

GRI$-10M

FCF (TTM)

DRMA$-8M

GRI$-10M

EPS (TTM)

DRMA-$2.08

GRI-$5.35

ROE (TTM)

DRMA-16667.0%

GRI-13403.0%

ROA (TTM)

DRMA-13014.0%

GRI-10683.0%

ROIC (TTM)

DRMA-16667.0%

GRI-13403.0%

Cash

DRMA$4M

GRI$11M

Debt

DRMA$0

GRI$0

Net Cash/Debt

DRMA$4M

GRI$11M

Current Ratio (TTM)

DRMA2.81x

GRI10.30x

Quick Ratio (TTM)

DRMA2.62x

GRI9.95x

Debt/Equity (TTM)

DRMA0.00x

GRI0.00x

Debt/Assets (TTM)

DRMA0.0%

GRI0.0%

Interest Coverage (TTM)

DRMAN/A

GRIN/A

Net Debt/EBITDA (TTM)

DRMA0.00x

GRI0.00x

Beta

DRMA0.58

GRI-1.09

52W Performance

DRMA-78.7%

GRI-96.7%

YTD Performance

DRMA-53.2%

GRI-77.8%

% from 52W High

DRMA-78.9%

GRI-97.3%

% from 52W Low

DRMA7.3%

GRI27.9%

Asset Turnover (TTM)

DRMA0.00x

GRI0.00x

FCF Yield (TTM)

DRMA-198.6%

GRI-338.3%

Earnings Yield (TTM)

DRMA-204.1%

GRI-313.6%

Dividend Yield (TTM)

DRMAN/A

GRIN/A

Rule of 40

DRMA0.0

GRI0.0

EV/GP/RG

DRMAN/A

GRIN/A

Ticker research

View DRMA research View GRI research

Metric	DRMA Dermata Therapeutics Inc	GRI GRI Bio Inc
Market & Valuation
Market Cap	$4M	$3M
Enterprise Value	$-312K	$-8M
Price	$1.02	$1.74
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.27x	0.42x
P/FCF Ratio	N/A	N/A
EV/FCF	0.04x	0.76x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	11.49x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	650.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-8M	$-10M
FCF (TTM)	$-8M	$-10M
EPS (TTM)	-$2.08	-$5.35
ROE (TTM)	-16667.0%	-13403.0%
ROA (TTM)	-13014.0%	-10683.0%
ROIC (TTM)	-16667.0%	-13403.0%
Financial Health
Cash	$4M	$11M
Debt	$0	$0
Net Cash/Debt	$4M	$11M
Current Ratio (TTM)	2.81x	10.30x
Quick Ratio (TTM)	2.62x	9.95x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	-1.09
52W Performance	-78.7%	-96.7%
YTD Performance	-53.2%	-77.8%
% from 52W High	-78.9%	-97.3%
% from 52W Low	7.3%	27.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-198.6%	-338.3%
Earnings Yield (TTM)	-204.1%	-313.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DRMA research	View GRI research

Valuation

P/S Ratio

DRMA

0.00x

GRI

0.00x

EV/FCF

DRMA

0.04x

GRI

0.76x

Growth & revenue

Forward Revenue Growth

DRMA

650.0%

GRI

0.0%

Profitability & performance

Gross Margin

DRMA

0.0%

GRI

0.0%

ROE

GRI

-13403.0%

DRMA

-16667.0%

FCF Yield %

DRMA

-198.6%

GRI

-338.3%

52-Week Performance

DRMA

-78.7%

GRI

-96.7%

Detailed metrics comparison

DRMA

Dermata Therapeutics Inc

GRI

GRI Bio Inc

Market Cap

DRMA$4M

GRI$3M

Enterprise Value

DRMA$-312K

GRI$-8M

Price

DRMA$1.02

GRI$1.74

P/E Ratio

DRMAN/A

GRIN/A

P/S Ratio

DRMA0.00x

GRI0.00x

EV/Sales

DRMA0.00x

GRI0.00x

EV/EBITDA

DRMA0.00x

GRI0.00x

P/B Ratio

DRMA1.27x

GRI0.42x

P/FCF Ratio

DRMAN/A

GRIN/A

EV/FCF

DRMA0.04x

GRI0.76x

PEG Ratio

DRMAN/A

GRIN/A

Forward P/E (NTM)

DRMAN/A

GRIN/A

Forward P/S (NTM)

DRMA11.49x

GRIN/A

Revenue (TTM)

DRMA$0

GRI$0

Revenue Growth (YoY)

DRMAN/A

GRIN/A

Forward Rev Growth

DRMA650.0%

GRI0.0%

Gross Margin (TTM)

DRMA0.0%

GRI0.0%

Operating Margin (TTM)

DRMA0.0%

GRI0.0%

EBITDA Margin (TTM)

DRMA0.0%

GRI0.0%

Net Margin (TTM)

DRMA0.0%

GRI0.0%

FCF Margin (TTM)

DRMAN/A

GRIN/A

Net Income (TTM)

DRMA$-8M

GRI$-10M

FCF (TTM)

DRMA$-8M

GRI$-10M

EPS (TTM)

DRMA-$2.08

GRI-$5.35

ROE (TTM)

DRMA-16667.0%

GRI-13403.0%

ROA (TTM)

DRMA-13014.0%

GRI-10683.0%

ROIC (TTM)

DRMA-16667.0%

GRI-13403.0%

Cash

DRMA$4M

GRI$11M

Debt

DRMA$0

GRI$0

Net Cash/Debt

DRMA$4M

GRI$11M

Current Ratio (TTM)

DRMA2.81x

GRI10.30x

Quick Ratio (TTM)

DRMA2.62x

GRI9.95x

Debt/Equity (TTM)

DRMA0.00x

GRI0.00x

Debt/Assets (TTM)

DRMA0.0%

GRI0.0%

Interest Coverage (TTM)

DRMAN/A

GRIN/A

Net Debt/EBITDA (TTM)

DRMA0.00x

GRI0.00x

Beta

DRMA0.58

GRI-1.09

52W Performance

DRMA-78.7%

GRI-96.7%

YTD Performance

DRMA-53.2%

GRI-77.8%

% from 52W High

DRMA-78.9%

GRI-97.3%

% from 52W Low

DRMA7.3%

GRI27.9%

Asset Turnover (TTM)

DRMA0.00x

GRI0.00x

FCF Yield (TTM)

DRMA-198.6%

GRI-338.3%

Earnings Yield (TTM)

DRMA-204.1%

GRI-313.6%

Dividend Yield (TTM)

DRMAN/A

GRIN/A

Rule of 40

DRMA0.0

GRI0.0

EV/GP/RG

DRMAN/A

GRIN/A

Ticker research

View DRMA research View GRI research

Metric	DRMA Dermata Therapeutics Inc	GRI GRI Bio Inc
Market & Valuation
Market Cap	$4M	$3M
Enterprise Value	$-312K	$-8M
Price	$1.02	$1.74
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.27x	0.42x
P/FCF Ratio	N/A	N/A
EV/FCF	0.04x	0.76x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	11.49x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	650.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-8M	$-10M
FCF (TTM)	$-8M	$-10M
EPS (TTM)	-$2.08	-$5.35
ROE (TTM)	-16667.0%	-13403.0%
ROA (TTM)	-13014.0%	-10683.0%
ROIC (TTM)	-16667.0%	-13403.0%
Financial Health
Cash	$4M	$11M
Debt	$0	$0
Net Cash/Debt	$4M	$11M
Current Ratio (TTM)	2.81x	10.30x
Quick Ratio (TTM)	2.62x	9.95x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	-1.09
52W Performance	-78.7%	-96.7%
YTD Performance	-53.2%	-77.8%
% from 52W High	-78.9%	-97.3%
% from 52W Low	7.3%	27.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-198.6%	-338.3%
Earnings Yield (TTM)	-204.1%	-313.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DRMA research	View GRI research